# Kura Oncology, Inc.: Form 8-K, filed Nov 7, 2024

- Company: [Kura Oncology, Inc.](/companies/kura.md) (CIK 1422143)
- Form: 8-K
- Filed: 2024-11-07
- Accepted by EDGAR: Nov 7, 2024, 16:10 ET
- Period: 2024-11-07
- Accession: 0000950170-24-123321
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1422143/000095017024123321/kura-20241107.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1422143/000095017024123321/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1422143/000095017024123321/kura-20241107.htm

Filed Nov 7, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-123321. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.